Publications by authors named "L Pantani"

Claim this Profile
A
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.
I Rizzello, I Sacchetti, S Barbato, V Solli, P Stefanoni, L Pantani

Clin Exp Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
M Talarico, S Barbato, V Maisnar, S Delimpasi, M Puppi, L Pantani

J Cancer Res Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma.
Marco Talarico, Gisella Vischini, Simona Barbato, Roberta Restuccia, Simone Masci, Lucia Pantani

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing.
M Puppi, I Sacchetti, K Mancuso, P Tacchetti, L Pantani

Mediterr J Hematol Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.
Flavia Bigi, Mauro Fiacchini, Roberta Restuccia, Simone Masci, Gaia Mazzocchetti, Lucia Pantani

Clin Exp Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis